Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Krone

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
JAMA|July 7, 2011
Appropriateness of percutaneous coronary interventionPaul S Chan, Manesh R Patel, Lloyd W Klein, et al.
Circulation|April 2, 2008
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data RegistryLeslee J Shaw, Richard E Shaw, C Noel Bairey Merz, et al.
Circulation|September 26, 2012
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialMaria Mori Brooks, Bernard R Chaitman, Richard W Nesto, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)J Matthew Brennan, Jeptha P Curtis, David Dai, et al.
Journal of the American College of Cardiology|May 1, 2010
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data RegistryEric D Peterson, David Dai, Elizabeth R DeLong, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2006
Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular proceduresMarc J Schweiger, Charles E Chambers, Charles J Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue SarcomaBrian A Van Tine, Angela C Hirbe, Peter Oppelt, et al.
The American Journal of Cardiology|July 16, 2005
Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarctionArthur J Moss, Daniel Ryan, David Oakes, et al.
The American Journal of Cardiology|April 29, 2015
Improving clinical practice guidelines for practicing cardiologistsJesaia Benhorin, Monty Bodenheimer, Mary Brown, et al.
Circulation|May 20, 1999
Thrombogenic factors and recurrent coronary eventsA J Moss, R E Goldstein, V J Marder, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
JAMA|July 7, 2011
Appropriateness of percutaneous coronary interventionPaul S Chan, Manesh R Patel, Lloyd W Klein, et al.
Circulation|April 2, 2008
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data RegistryLeslee J Shaw, Richard E Shaw, C Noel Bairey Merz, et al.
Circulation|September 26, 2012
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trialMaria Mori Brooks, Bernard R Chaitman, Richard W Nesto, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)J Matthew Brennan, Jeptha P Curtis, David Dai, et al.
Journal of the American College of Cardiology|May 1, 2010
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data RegistryEric D Peterson, David Dai, Elizabeth R DeLong, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 2, 2006
Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular proceduresMarc J Schweiger, Charles E Chambers, Charles J Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue SarcomaBrian A Van Tine, Angela C Hirbe, Peter Oppelt, et al.
The American Journal of Cardiology|July 16, 2005
Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarctionArthur J Moss, Daniel Ryan, David Oakes, et al.
The American Journal of Cardiology|April 29, 2015
Improving clinical practice guidelines for practicing cardiologistsJesaia Benhorin, Monty Bodenheimer, Mary Brown, et al.
Circulation|May 20, 1999
Thrombogenic factors and recurrent coronary eventsA J Moss, R E Goldstein, V J Marder, et al.
Pageof 15